subgroup of
drug)
→
ReceivesAction
→
tested on animal
| Typicality: | 0.536 |
| Saliency: | 0.341 |
| at this stage | 5 | temporal |
| for early embryonic development | 2 | purpose |
| new drug → be tested on → animal | 8 |
| new drug → be tested in → animal | 4 |
| negative | neutral | positive |
| 0.228 | 0.676 | 0.097 |
| Raw frequency | 12 |
| Normalized frequency | 0.341 |
| Modifier score | 0.933 |
| Perplexity | 57.799 |